Teduglutide vs Motilin
Head-to-head comparison of Teduglutide (Teduglutide (glycyl-2 human glucagon-like peptide-2 analog)) and Motilin (Motilin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Teduglutide | Motilin |
|---|---|---|
| Category | Gastrointestinal | Gastrointestinal |
| Full Name | Teduglutide (glycyl-2 human glucagon-like peptide-2 analog) | Motilin |
| Molecular Weight | 3752 Da | ~2.7 kDa |
| Half-Life | approximately 2-3 hours | ~20 min |
| Amino Acids | 33 | 22 |
| Typical Dose | 0.05 mg/kg/day | No standard approved dose; experimental use only |
| Route | Subcutaneous | IV|SC |
| Purity | ≥98% | ≥98% |
| Studies Count | 300 | 81 |
| Research Status | Clinical | Endogenous |
Teduglutide Benefits
- ✓mucosal-growth
- ✓absorption-support
- ✓barrier-repair
- ✓intestinal-adaptation
Motilin Benefits
- ✓migrating motor complex support
- ✓gastric emptying
- ✓small-bowel clearance
Teduglutide Dosing
0.05 mg/kg once daily subcutaneous injection|chronic maintenance dosing in approved use|monitor fluid status and intestinal anatomy
Motilin Dosing
0.1–1 mg (experimental)|IV/SC
Teduglutide Side Effects
- ⚠abdominal pain
- ⚠fluid retention
- ⚠polyp/neoplasia monitoring needed
Motilin Side Effects
- ⚠cramping
- ⚠nausea
Research Overview
Teduglutide
Teduglutide has robust clinical evidence showing improved intestinal absorption and reduced parenteral nutrition dependence in short bowel syndrome. Its mechanism, via GLP-2 receptor activation, makes it highly relevant to mucosal healing and intestinal adaptation research.
Motilin
Motilin is a 22-amino-acid peptide released from the upper small intestine and is one of the classic physiologic prokinetic signals. It is a real peptide target for GI motility research, though not commonly used as a standard drug.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.